Release Date: 09/12/10 17:07 Summary: Deferral of Shareholder Meeting Price Sensitive: Yes Download Document 84.42KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%